Ninepoint Partners LP

SEC CIK: 0001715635
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

ASND holding history

Ascendis Pharma A/S in every 13F filed by Ninepoint Partners LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overview All 13F holders of ASND Full Q2 2026 holdings

Shares (Q2 2026): 26
Value: $6.93K
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of ASND by Ninepoint Partners LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	26	$6.93K	<0.1%	−5,400−99.5%	Reduced	Holders
Q1 2026	5,426	$1.24M	0.1%	+3,311+156.5%	Added	Holders
Q4 2025	2,115	$451.0K	0.1%	+1,366+182.4%	Added	Holders
Q3 2025	749	$148.9K	<0.1%	+749	New	Holders